BREAKING

Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 hour ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 3 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 4 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 5 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 6 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 8 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 8 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 9 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 9 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 9 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 1 hour ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 3 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 4 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 5 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 6 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 8 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 8 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 9 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 9 hours ago Innovation and E-Commerce at the Core of Johnson Outdoors’ 2026 Roadmap 9 hours ago

ADVERTISEMENT

AlphaGraphs

Key highlights from AngioDynamics (ANGO) Q4 2020 earnings results

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019 Net sales decreased 41% to $58.3 million […]

$ANGO July 16, 2020 1 min read

AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020.

Net loss for the fourth quarter was $156 million, or $4.10 per share, compared to net loss of $165.8 million, or $4.37 per share in the fourth quarter of 2019
Net sales decreased 41% to $58.3 million
Capital expenditures during the quarter was $1.5 million

Looking forward to listening to management/analysts comments on Q4 results? Stay tuned here for AngioDynamics Q4 2020 earnings call transcript

AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results

ADVERTISEMENT